SMAD2 and atherosclerosis: In vitro experiments confirmed that BYHWD can reverse the inhibition of the Foxp3/TGF-β/Smad2 pathway caused by blockers, thereby promoting Treg differentiation and improving atherosclerosis (Chen S. et al., 2021).